Sens. Klobuchar, Collins push drug-shortage bill

Share this article:
Sen. Susan Collins (R-ME)
Sen. Susan Collins (R-ME)

U.S. senators Amy Klobuchar (D-MN) and Susan Collins (R-ME) are urging their fellow lawmakers to quickly pass a bipartisan bill aimed at addressing the growing drug shortage problem in the U.S.

“The shortages of these vital drugs are causing serious problems around the country,” said Collins in a statement. “Our legislation aims to give the FDA the tools and information they need to prevent drug shortages.”

The Preserving Access to Life-Saving Medications Act, which  Klobuchar introduced  last year, would require drug companies to give  FDA six months notice of any discontinuance, interruption, or other adjustment of a drug's manufacturing process that would likely result in a shortage. Notification would be required for adjustments related to raw materials supply, production capabilities and other reasons deemed appropriate by the HHS secretary.

A stakeholders group has called for exploring incentives such as tax credits for producing critical drug products or upgrading manufacturing plants. They also recommend an expedited approval pathway.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Legal/Regulatory


Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.